Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3229636
Max Phase: Preclinical
Molecular Formula: C48H73N11O12S2
Molecular Weight: 1060.31
Molecule Type: Small molecule
Associated Items:
ID: ALA3229636
Max Phase: Preclinical
Molecular Formula: C48H73N11O12S2
Molecular Weight: 1060.31
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O
Standard InChI: InChI=1S/C48H73N11O12S2/c1-5-27(4)40-46(70)54-30(15-16-36(49)61)42(66)55-33(22-37(50)62)43(67)57-34(47(71)59-19-9-10-35(59)45(69)56-31(20-26(2)3)41(65)52-24-38(51)63)25-72-73-48(17-7-6-8-18-48)23-39(64)53-32(44(68)58-40)21-28-11-13-29(60)14-12-28/h11-14,26-27,30-35,40,60H,5-10,15-25H2,1-4H3,(H2,49,61)(H2,50,62)(H2,51,63)(H,52,65)(H,53,64)(H,54,70)(H,55,66)(H,56,69)(H,57,67)(H,58,68)/t27-,30-,31-,32-,33-,34-,35-,40-/m0/s1
Standard InChI Key: XVHKLYUECKAVIL-SZQHDTAUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1060.31 | Molecular Weight (Monoisotopic): 1059.4882 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Lowbridge J, Manning M, Seto J, Haldar J, Sawyer WH.. (1979) Synthetic antagonists of in vivo responses by the rat uterus to oxytocin., 22 (5): [PMID:458806] [10.1021/jm00191a019] |
2. Hruby VJ, Deb KK, Yamamoto DM, Hadley ME, Chan WY.. (1979) [1-Penicillamine,2-leucine]oxytocin. Synthesis and pharmacological and conformational studies of a potent peptide hormone inhibitor., 22 (1): [PMID:423185] [10.1021/jm00187a002] |
3. Manning M, Lowbridge J, Seto J, Haldar J, Sawyer WH.. (1978) [1-Deaminopenicillamine,4-threonine]oxytocin, a potent inhibitor of oxytocin., 21 (2): [PMID:621712] [10.1021/jm00200a007] |
Source(1):